• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.SCARA5 的遗传和表观遗传沉默可能通过激活 FAK 信号通路促进人肝癌的发生。
J Clin Invest. 2010 Jan;120(1):223-41. doi: 10.1172/JCI38012. Epub 2009 Dec 14.
2
Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis.A 类清道夫受体成员 5 的治疗性上调抑制肿瘤生长和转移。
Cancer Sci. 2012 Sep;103(9):1631-9. doi: 10.1111/j.1349-7006.2012.02350.x. Epub 2012 Aug 17.
3
SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.SPAG5 通过调节β-catenin 降解来下调 SCARA5 促进肝癌进展。
J Exp Clin Cancer Res. 2018 Sep 18;37(1):229. doi: 10.1186/s13046-018-0891-3.
4
Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.SCARA5的过表达通过抑制FAK信号通路抑制骨肉瘤的肿瘤增殖和侵袭。
Mol Med Rep. 2016 Mar;13(3):2885-91. doi: 10.3892/mmr.2016.4857. Epub 2016 Feb 3.
5
Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.碳酸酐酶4通过激活黏着斑激酶-原癌基因酪氨酸蛋白激酶Src信号通路促进肝细胞癌的肿瘤生长和转移。
J Pathol. 2014 Nov;234(3):316-28. doi: 10.1002/path.4395. Epub 2014 Aug 18.
6
Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.SOCS-3的甲基化沉默通过增强人肝细胞癌中的JAK/STAT和FAK信号传导促进细胞生长和迁移。
Oncogene. 2005 Sep 22;24(42):6406-17. doi: 10.1038/sj.onc.1208788.
7
CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.CSN5 通过抑制 SCARA5 来抑制 β-连环蛋白泛素化从而促进肝癌进展。
Dig Dis Sci. 2018 Jan;63(1):155-165. doi: 10.1007/s10620-017-4855-9. Epub 2017 Nov 30.
8
LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.长链非编码 RNA DBH-AS1 通过 FAK/Src/ERK 通路靶向 miR-138 促进肝癌的发生。
Biomed Pharmacother. 2018 Nov;107:824-833. doi: 10.1016/j.biopha.2018.08.079. Epub 2018 Aug 22.
9
Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.肝细胞癌中p16、SLIT2、SCARA5和Runx3基因的甲基化分析
Medicine (Baltimore). 2017 Oct;96(41):e8279. doi: 10.1097/MD.0000000000008279.
10
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.粘着斑激酶缺失通过抑制zeste同源物2增强子来降低人肝癌生长。
Cell Death Differ. 2017 May;24(5):889-902. doi: 10.1038/cdd.2017.34. Epub 2017 Mar 24.

引用本文的文献

1
Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication.急性髓系白血病中的铁蛋白:不仅是炎症和铁过载的标志物,也是细胞铁代谢、信号传导和通讯的调节因子。
Int J Mol Sci. 2025 Jun 15;26(12):5744. doi: 10.3390/ijms26125744.
2
Loss of miR-424 and miR-503 promotes decidualization of human endometrial stromal cells by increasing SCARA5 expression.miR-424和miR-503的缺失通过增加SCARA5表达促进人子宫内膜基质细胞的蜕膜化。
Med Mol Morphol. 2025 Mar 14. doi: 10.1007/s00795-025-00431-5.
3
Genome-wide association study of urinary cadmium levels in current smokers from the multiethnic cohort study.多民族队列研究中当前吸烟者尿镉水平的全基因组关联研究。
Hum Mol Genet. 2025 Mar 20;34(7):611-616. doi: 10.1093/hmg/ddae202.
4
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.G9a/DNMT1 共靶向抑制非小细胞肺癌生长,并通过 SCARA5 和 AOX1 使肿瘤细胞重编程以响应癌症药物。
Cell Death Dis. 2024 Nov 2;15(11):787. doi: 10.1038/s41419-024-07156-w.
5
The Role of SCARA5 as a Potential Biomarker in Squamous Cell Carcinoma of the Lung.SCARA5 在肺鳞癌中作为潜在生物标志物的作用。
Int J Mol Sci. 2024 Jul 4;25(13):7355. doi: 10.3390/ijms25137355.
6
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis.SCARA5在前列腺癌中过表达并与预后不良相关。
Diagnostics (Basel). 2023 Jun 29;13(13):2211. doi: 10.3390/diagnostics13132211.
7
Decreased expression of predicts a poor prognosis in melanoma using bioinformatics analysis.使用生物信息学分析表明,[具体内容]表达降低预示黑色素瘤预后不良。 (你提供的原文中“Decreased expression of ”后面缺少具体所指内容)
Front Oncol. 2023 Mar 24;13:1015358. doi: 10.3389/fonc.2023.1015358. eCollection 2023.
8
SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.SCARA5 通过与转铁蛋白轻链结合诱导铁死亡从而影响 ESCC 的增殖和转移。
BMC Cancer. 2022 Dec 13;22(1):1304. doi: 10.1186/s12885-022-10414-9.
9
Highly Expressing Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.高表达促进食管鳞癌细胞的增殖和迁移。
J Immunol Res. 2022 Jun 17;2022:2555647. doi: 10.1155/2022/2555647. eCollection 2022.
10
SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer.SCARA3 通过 AKT 信号通路抑制肺癌细胞增殖和 EMT。
BMC Cancer. 2022 May 16;22(1):552. doi: 10.1186/s12885-022-09631-z.

本文引用的文献

1
Signal transduction by focal adhesion kinase in cancer.粘着斑激酶在癌症中的信号转导
Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4.
2
FERM control of FAK function: implications for cancer therapy.FERM对粘着斑激酶功能的调控:对癌症治疗的启示
Cell Cycle. 2008 Aug;7(15):2306-14. doi: 10.4161/cc.6367. Epub 2008 May 29.
3
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.DLC1是一种位于8号染色体短臂的肿瘤抑制基因,其缺失会促进肝细胞癌的发生。
Genes Dev. 2008 Jun 1;22(11):1439-44. doi: 10.1101/gad.1672608.
4
DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.DLC1通过降低RhoA GTP酶活性、破坏肌动蛋白细胞骨架以及下调参与转移的基因,抑制人肝癌细胞在裸鼠中的远处播散。
Int J Oncol. 2008 Jun;32(6):1285-91. doi: 10.3892/ijo_32_6_1285.
5
Focal adhesion kinase versus p53: apoptosis or survival?粘着斑激酶与p53:凋亡还是存活?
Sci Signal. 2008 May 20;1(20):pe22. doi: 10.1126/stke.120pe22.
6
CpG island methylator phenotype (CIMP) in cancer: causes and implications.癌症中的CpG岛甲基化表型(CIMP):成因与影响
Cancer Lett. 2008 Sep 18;268(2):177-86. doi: 10.1016/j.canlet.2008.03.022. Epub 2008 May 8.
7
Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway.碳酸酐酶III通过FAK信号通路促进肝癌细胞的转化和侵袭能力。
Mol Carcinog. 2008 Dec;47(12):956-63. doi: 10.1002/mc.20448.
8
Focal adhesion kinase as a regulator of cell tension in the progression of cancer.粘着斑激酶作为癌症进展中细胞张力的调节因子。
Semin Cancer Biol. 2008 Feb;18(1):45-52. doi: 10.1016/j.semcancer.2007.08.002. Epub 2007 Sep 4.
9
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.乳腺癌和肺癌中ras效应器/肿瘤抑制因子RASSF2的表观遗传调控
Oncogene. 2008 Mar 13;27(12):1805-11. doi: 10.1038/sj.onc.1210805. Epub 2007 Sep 24.
10
Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中8p21.3-p22杂合性缺失区域的基因组评估
Cancer Genet Cytogenet. 2007 Jul 15;176(2):100-6. doi: 10.1016/j.cancergencyto.2007.04.003.

SCARA5 的遗传和表观遗传沉默可能通过激活 FAK 信号通路促进人肝癌的发生。

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

机构信息

National Human Genome Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine, 351 Guo Shou-Jing Road, Shanghai, People's Republic of China.

出版信息

J Clin Invest. 2010 Jan;120(1):223-41. doi: 10.1172/JCI38012. Epub 2009 Dec 14.

DOI:10.1172/JCI38012
PMID:20038795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2798676/
Abstract

The epigenetic silencing of tumor suppressor genes is a crucial event during carcinogenesis and metastasis. Here, in a human genome-wide survey, we identified scavenger receptor class A, member 5 (SCARA5) as a candidate tumor suppressor gene located on chromosome 8p. We found that SCARA5 expression was frequently downregulated as a result of promoter hypermethylation and allelic imbalance and was associated with vascular invasion in human hepatocellular carcinoma (HCC). Furthermore, SCARA5 knockdown via RNAi markedly enhanced HCC cell growth in vitro, colony formation in soft agar, and invasiveness, tumorigenicity, and lung metastasis in vivo. By contrast, SCARA5 overexpression suppressed these malignant behaviors. Interestingly, SCARA5 was found to physically associate with focal adhesion kinase (FAK) and inhibit the tyrosine phosphorylation cascade of the FAK-Src-Cas signaling pathway. Conversely, silencing SCARA5 stimulated the signaling pathway via increased phosphorylation of certain tyrosine residues of FAK, Src, and p130Cas; it was also associated with activation of MMP9, a tumor metastasis-associated enzyme. Taken together, these data suggest that the plasma membrane protein SCARA5 can contribute to HCC tumorigenesis and metastasis via activation of the FAK signaling pathway.

摘要

表观遗传抑制肿瘤抑制基因是癌发生和转移过程中的一个关键事件。在这里,在一个人类全基因组调查中,我们确定了清道夫受体 A 成员 5(SCARA5)作为位于 8p 染色体上的候选肿瘤抑制基因。我们发现,由于启动子过度甲基化和等位基因失衡,SCARA5 的表达经常下调,并且与人类肝细胞癌(HCC)中的血管侵犯有关。此外,通过 RNAi 敲低 SCARA5 可显著增强 HCC 细胞在体外的生长、软琼脂中的集落形成以及体内的侵袭性、致瘤性和肺转移。相比之下,SCARA5 的过表达抑制了这些恶性行为。有趣的是,发现 SCARA5 与粘着斑激酶(FAK)物理结合,并抑制 FAK-Src-Cas 信号通路的酪氨酸磷酸化级联反应。相反,沉默 SCARA5 通过增加 FAK、Src 和 p130Cas 的某些酪氨酸残基的磷酸化来刺激信号通路;它还与肿瘤转移相关酶 MMP9 的激活有关。总之,这些数据表明,质膜蛋白 SCARA5 可以通过激活 FAK 信号通路促进 HCC 的发生和转移。